Returning to the prion disease context, since DPP4-mediated β-cleavage of PrPC seems to promote PrPSc accumulation in primary cerebellar glial cultures, brain-penetrant DPP4 inhibitors could be tested in animal models of prion infections. This evidence concerns the gene DPP4 and prion disease.